Several lncRNAs like ZFAS1, MALAT1, H19 have been shown to increase resistance to cisplatin while lncRNA like GAS5, NEAT1 lower cisplatin resistance in ovarian cancer cells [135]. This evidence concerns the gene H19 and ovarian carcinoma.